Document is current
Any future updates will be listed below
-
Authors
Bath, Philip M https://orcid.org/0000-0003-2734-5132
Mhlanga, Iris
Woodhouse, Lisa J https://orcid.org/0000-0002-4472-1999
Doubal, Fergus https://orcid.org/0000-0002-2769-3148
Oatey, Katherine
Montgomery, Alan A
Wardlaw, Joanna M https://orcid.org/0000-0002-9812-6642
-
Clinical Trials BETA
Clinical trials referenced in this document:
isrctn14911850 at ISRCTN.orgisrctn14911850 at ISRCTN.orgDocuments that mention this clinical trial
Correction: <i>Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)</i>
https://doi.org/10.1136/svn-2022-001816corr1
Carbon footprint of a sample of clinical trials for people with neurological disorders: cross-sectional analysis
https://doi.org/10.1136/bmjopen-2024-090419
Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)
https://doi.org/10.1136/svn-2022-001816
Documents that mention this clinical trial
Correction: <i>Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)</i>
https://doi.org/10.1136/svn-2022-001816corr1
Carbon footprint of a sample of clinical trials for people with neurological disorders: cross-sectional analysis
https://doi.org/10.1136/bmjopen-2024-090419
Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)
https://doi.org/10.1136/svn-2022-001816
-
Funding
Funding for this research was provided by:
Horizon 2020 Framework Programme (666881)
British Heart Foundation (CS/15/5/31475)
Alzheimer’s Society (AS-PG-14–033)
Fondation Leducq (16/05 CVD)
- License Information
